Space F (Biotechnology) Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $15M

  • Investors
  • 8

Space F (Biotechnology) General Information

Description

Developer of cell farming technology intended to provide meat alternative food products. The company's technology uses stem cell and tissue engineering techniques to extract and cultivate animal cells to make livestock substitutes, enabling customers to get sustainable and safe alternative food items.

Contact Information

Website
spacef.biz
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 806 The First Tower
  • 10 Dongtan-daero 21-gil, Gyeonggi-do
  • Hwaseong, 18471
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Corporate Office
  • 806 The First Tower
  • 10 Dongtan-daero 21-gil, Gyeonggi-do
  • Hwaseong, 18471
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Space F (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 05-May-2022 $15M Completed Generating Revenue
2. Early Stage VC (Series A) 25-Aug-2021 Completed Generating Revenue
1. Seed Round 01-Apr-2021 Completed Generating Revenue
To view Space F (Biotechnology)’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Space F (Biotechnology) Patents

Space F (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250129331-A1 Medium composition for culture of extraembryonic endoderm stem cells Pending 23-Feb-2023
WO-2024177208-A1 Medium composition for culture of extraembryonic endoderm stem cells Inactive 23-Feb-2023
EP-4495229-A1 Medium composition for culturing porcine pluripotent stem cells Pending 14-Mar-2022
EP-4495229-A4 Medium composition for culturing porcine pluripotent stem cells Pending 14-Mar-2022
US-20250051724-A1 Medium composition for culturing porcine pluripotent stem cells Pending 14-Mar-2022 C12N5/0606
To view Space F (Biotechnology)’s complete patent history, request access »

Space F (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Space F (Biotechnology) Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ministry of Trade, Industry and Resources Limited Partner Minority
CJ Investment Corporate Venture Capital Minority
Daesang Corporation Minority
DAYLI Partners Venture Capital Minority
Lotte Ventures Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Space F (Biotechnology) FAQs

  • When was Space F (Biotechnology) founded?

    Space F (Biotechnology) was founded in 2020.

  • Where is Space F (Biotechnology) headquartered?

    Space F (Biotechnology) is headquartered in Hwaseong, South Korea.

  • What is the size of Space F (Biotechnology)?

    Space F (Biotechnology) has 18 total employees.

  • What industry is Space F (Biotechnology) in?

    Space F (Biotechnology)’s primary industry is Biotechnology.

  • Is Space F (Biotechnology) a private or public company?

    Space F (Biotechnology) is a Private company.

  • What is Space F (Biotechnology)’s current revenue?

    The current revenue for Space F (Biotechnology) is .

  • How much funding has Space F (Biotechnology) raised over time?

    Space F (Biotechnology) has raised $6.04M.

  • Who are Space F (Biotechnology)’s investors?

    Ministry of Trade, Industry and Resources, CJ Investment, Daesang, DAYLI Partners, and Lotte Ventures are 5 of 8 investors who have invested in Space F (Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process